Skip to main content

SMHC Cancer Care - Outcomes

napbc mhccn logosSMHC is a proud partner of the MaineHealth Cancer Care Network. ­ This outcomes report summarizes some of the cancer care activities and results that have been completed or achieved at SMHC in 2019. It includes information about screening programs, clinical measures and quality improvement and shows how we compare to national standards.

  • Early Detection Saves Lives: Breast and colorectal cancer are among the top four cancers in Maine, which has the highest rate of cancer deaths in the nation. Mammography and colonoscopy procedures are excellent screening tools that can catch cancer early, when it’s easier to treat. Early detection can result in a shorter course of treatment and improves patient outcomes.

  • Colonoscopy Screening: Colon cancer typically grows slowly, and colonoscopy is the most common screening test used to detect it. For people at average risk for developing colorectal cancer, the recommended age to begin screening is 50. In 2018, SMHC exceeded the average national colonoscopy rate for patients 50 and older, by screening 75% of patients.

Colon Cancer Outcomes

SMHC exceeded the Commission on Cancer’s (CoC) required performance expectations for the most recent reporting period.

Oncology Metric
Number of SMHC Cases Submitted
CoC Required Performance Rate
SMHC Performance Rate
At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer. (Quality Improvement)

 11  85%  100%
Preoperative chemo and radiation are administered for clinical AJCC T3N0, T4N0, or Stage III, or postoperative chemo and  radiation are administered within 180 days of diagnosis for clinical AJCC stage III (node positive) colon cancer. (Surveillance)  2  85%  100%

 


Breast Cancer Outcomes

SMHC exceeded the Commission on Cancer’s (CoC) required performance expectations for the most recent reporting period.

Oncology Metric
Number of SMHC Cases Submitted
CoC Required Performance Rate
SMHC Performance Rate
Radiation is administered within 1 year (365 days) of diagnosis for women under age  of 70 receiving breast conserving surgery for breast cancer. (Accountability)

 18  80%  100%
Preoperative chemo and radiation are administered for clinical AJCC T3N0, T4N0, or Stage III, or postoperative chemo and  radiation are administered within 180 days of diagnosis for clinical AJCC stage III (node positive) colon cancer. (Surveillance)

 35  90%  97.1%
Radiation therapy is considered or administered following any mastectomy within 1 year (365 days)
of diagnosis of breast cancer for women with > = 4  1 positive regional lymph nodes. (Accountability)

 1  90%  100%
Image or palpitation-guided needle biopsy (core or FNA) of the primary site is performed to establish diagnosis of breast cancer. (Quality Improvement) 78  80%  98.7%

 



Lung Cancer Screening Criteria

You must meet all of the following to benefit from a low-dose CAT scan:

  • Age 55-77
  • 30 pack-year history
  • Still smoking or quit within the past 15 years
  • No major health problems preventing you from receiving lung cancer surgery

Lung Cancer Outcomes

SMHC exceeded the Commission on Cancer’s (CoC) required performance expectations for the most recent reporting period.

Oncology Metric
Number of SMHC Cases Submitted
CoC Required Performance Rate
SMHC Performance Rate
Radiation is administered within 1 year (365 days) of diagnosis for women under age  of 70 receiving breast conserving surgery for breast cancer. (Accountability)

 1  85%  100%